
Using Memantine to Prevent Alzheimer’s
NAMENDA® / EBIXA® (generic MEMANTINE) is FDA-approved for Alzheimer’s. Learn about new research on how it may help in preventing or slowing dementia.
NAMENDA® / EBIXA® (generic MEMANTINE) is FDA-approved for Alzheimer’s. Learn about new research on how it may help in preventing or slowing dementia.
Research shows that lecanemab is the first drug ever to slow cognitive decline in Alzheimer’s. Learn more.
Researchers have found both smoking and cardiovascular disease impair the ability to learn and memorize. Find out more.
People with Alzheimer’s are often prescribed drugs for other conditions — including diabetes or high blood pressure — at the same doses as those without dementia. That practice might need to be reexamined.
The FDA has approved the supplemental New Drug Application (sNDA) of REXULTI® (brexpiprazole) for the treatment of agitation associated with Alzheimer’s. It’s the first such treatment to be approved in the US. Learn more.
See safety and effectiveness rankings for four Alzheimer’s drugs. Ranked on concentration, memory, alertness and mood, learn what the researchers found.
An international team of researchers finds that cognitive motor training helps fight Alzheimer’s and dementia, using a fitness game to show that cognitive motor training improves both cognitive and physical skills in people with significant dementia. Find out more.
A global team of scientists has found by tracking the health of more than 31,000 adults through six longitudinal studies that treating high blood pressure with medication reduces the risk of dementia by 12 percent. It reduces the risk of developing Alzheimer’s disease even more – by 16 percent. Find out why.
Researchers in Canada find that listening to one’s favorite music, or to music that is personally significant, leads to improvement in the integrity of the brain.
A new peptide may hold potential as an Alzheimer’s treatment
Researchers say the CDK5 Blocker peptide blocks a hyperactive brain enzyme that contributes to the neurodegeneration seen in Alzheimer’s and other diseases.
The new Alzheimer’s antibodies, Leqembi and Kisunla, work better on some people than others. A cutting-edge technique called spatial transcriptomics may help figure out how to make them work better for everybody.
VIDEO: This is not a story about dementia. This is a story about Liz.
EXTRAORDINARY MUSIC VIDEO: Ted McDermott, The Song-A-Minute Man, was diagnosed with dementia. His son, Simon, wasn’t going to let that stop his Dad. He understood how music reaches our deepest selves and has journeyed with his Dad and their dashcam to make beautiful music together. Get your widest smile ready and watch them in action.
Three important dementia studies focus on HS-AGING, a type of dementia almost as common as Alzheimer’s in the 85+ group. Yet few people have heard of it. Why? What makes it different?
An intriguing study of 120 grandmothers might surprise you. Doctors know socially engaged people have better cognition and less dementia. But can a person get too much of a good thing? What’s the right balance?
Enjoy this great duet between a musician with dementia and his son. A triumph of spirit over Alzheimer’s! Sing-a-long if you like!
No spam, only news and updates.